Device Molecular Diagnostics

Cobas 6800 System

Payments companies reported to CMS as associated with Cobas 6800 System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$63Kassociated payments (2023-2025)
25clinicians with associated payments
3companies reporting

By year

2023 $63K
2024 $21.37
2025 $176

Payments reported as associated with Cobas 6800 System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Cardiovascular Disease $17K
Maternal & Fetal Medicine $13K
Advanced Heart Failure and Transplant Cardiology $8,850
Neurology (Psychiatry & Neurology) $5,775
Emergency Medicine $4,509
Obstetrics & Gynecology $4,509

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cobas 6800 System

These are the largest totals companies reported as associated with Cobas 6800 System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Stephen Greene Durham, NC Advanced Heart Failure and Transplant Cardiology $8,850.00
James Januzzi Boston, MA Cardiovascular Disease $4,800.00
Jimmy Espinoza Houston, TX Maternal & Fetal Medicine $4,520.44
William Peacock Houston, TX Emergency Medicine $4,509.00
Scott Shainker Boston, MA Obstetrics & Gynecology $4,508.50
Richard Burwick West Covina, CA Maternal & Fetal Medicine $4,406.75
Subbian Karumanchi Boston, MA Nephrology (Internal Medicine) $4,392.22
Yader Sandoval Pichardo Minneapolis, MN Cardiovascular Disease $3,955.00
Sarosh Rana Chicago, IL Maternal & Fetal Medicine $3,652.42
Lori Daniels San Diego, CA Cardiovascular Disease $3,462.00

Prescribed Cobas 6800 System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.